We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PENG
1526
Penguin Solutions Inc
PENG
$2.7B
| $243K | ﹤0.01% |
+14,102
| New | +$236K |
|
1527
Hormel Foods
HRL
$13.9B
| $243K | ﹤0.01% |
6,092
-1,364
| -18% | -$58.9K |
|
1528
Titan Machinery
TITN
$423M
| $243K | ﹤0.01% |
+7,971
| New | +$325K |
|
1529
Becton Dickinson
BDX
$46.9B
| $243K | ﹤0.01% |
980
+100
| +11% | +$24.5K |
|
1530
Murphy Oil
MUR
$5.55B
| $242K | ﹤0.01% |
6,552
-1,812
| -22% | -$72.4K |
|
1531
Robert Half
RHI
$3.96B
| $242K | ﹤0.01% |
3,004
-7,494
| -71% | -$595K |
|
1532
CDW
CDW
$18.9B
| $242K | ﹤0.01% |
1,241
-1,589
| -56% | -$312K |
|
|
APLS
1533
DELISTED
Apellis Pharmaceuticals
APLS
| $241K | ﹤0.01% |
+3,650
| New | +$211K |
|
1534
Brinker International
EAT
$9.66B
| $240K | ﹤0.01% |
6,326
-22,372
| -78% | -$847K |
|
|
P
1535
PUT
Everpure Inc
P
$26.6B
| $240K | ﹤0.01% |
9,400
| – | – |
|
1536
FTC Solar
FTCI
$45.6M
| $240K | ﹤0.01% |
10,646
+8,140
| +325% | +$217K |
|
1537
WD-40
WDFC
$3.05B
| $238K | ﹤0.01% |
+1,339
| New | +$231K |
|
|
FRC
1538
DELISTED
First Republic Bank
FRC
| $238K | ﹤0.01% |
+17,033
| New | +$1.75M |
|
1539
DHT Holdings
DHT
$2.98B
| $238K | ﹤0.01% |
+21,986
| New | +$221K |
|
|
RVNC
1540
DELISTED
Revance Therapeutics, Inc.
RVNC
| $237K | ﹤0.01% |
+7,373
| New | +$230K |
|
1541
Wave Life Sciences
WVE
$1.13B
| $237K | ﹤0.01% |
+54,841
| New | +$251K |
|
1542
Spire
SR
$4.73B
| $236K | ﹤0.01% |
3,370
+321
| +11% | +$22.8K |
|
1543
CALL
Lockheed Martin
LMT
$135B
| $236K | ﹤0.01% |
500
-100
| -17% | -$46.9K |
|
1544
Bank of Hawaii
BOH
$3.16B
| $236K | ﹤0.01% |
+4,529
| New | +$318K |
|
1545
CALL
Tanger
SKT
$4.68B
| $236K | ﹤0.01% |
12,000
| – | – |
|
1546
Ameris Bancorp
ABCB
$5.92B
| $235K | ﹤0.01% |
+6,416
| New | +$288K |
|
|
NXDR
1547
Nextdoor Holdings
NXDR
$866M
| $234K | ﹤0.01% |
+108,925
| New | +$232K |
|
|
FFWM
1548
DELISTED
First Foundation Inc
FFWM
| $233K | ﹤0.01% |
31,330
-104,508
| -77% | -$1.4M |
|
1549
Parsons
PSN
$5.09B
| $233K | ﹤0.01% |
+5,215
| New | +$229K |
|
1550
Brookdale Senior Living
BKD
$3.43B
| $232K | ﹤0.01% |
+78,557
| New | +$226K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.